COMMUNIQUÉS West-GlobeNewswire

TRACON Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
CytomX Therapeutics Announces First Quarter 2018 Financial Results
09/05/2018
- Initial clinical data from the Phase 1/2 CX-072 program to be reported at American Society of Clinical Oncology Annual Meeting - SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc [...]
ICU Medical, Inc. Announces First Quarter 2018 Results
09/05/2018
SAN CLEMENTE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
XOMA Reports First Quarter 2018 Financial Results
09/05/2018
Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA ), a pioneer in the discovery, development and licensing of [...]
MRI Interventions, Inc. to Announce First Quarter 2018 Results on May 15
09/05/2018
IRVINE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 first quarter, which ended March 31, 2018, on Tuesday, May 15, 2018 [...]
Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results
09/05/2018
PLYMOUTH MEETING, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ), a late-stage biotechnology company focused on the discovery, development, and commercialization of DNA immunotherapies [...]
Wright Medical Group N.V. Reports 2018 First Quarter Financial Results
09/05/2018
First Quarter 2018 Net Sales of $199 Million First Quarter 2018 Net Loss From Continuing Operations of $20 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $27 Million U.S. Upper Extremities Business [...]
Adamas Announces New Employment Inducement Grant
09/05/2018
EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted four new employees the option [...]
Fluidigm to Participate in Upcoming Investor Events
09/05/2018
SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ), an innovative life science company that develops, manufactures and markets multiparameter mass cytometry technology and [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018
09/05/2018
Reports Net Revenues of $58.4 Million for the Three Months Ended March 31, 2018 RANCHO CUCAMONGA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) (“Amphastar” or the “Company”) [...]
Novavax Reports First Quarter 2018 Financial Results
09/05/2018
GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX ) today announced its financial results for the first quarter ended March 31, 2018. First Quarter and Subsequent Achievements: RSV F [...]
ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights
09/05/2018
-- Patient enrollment in Phase III ADVOCATE trial of avacopan in the treatment of ANCA-associated vasculitis exceeds 85%; Conditional Marketing Authorization (CMA) application under review with European Medicines Agency [...]
Portola Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
-- Conference Call Today at 4:30 p.m. ET -- SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today reported financial results for the three months ended March [...]
Aileron Therapeutics Reports First Quarter 2018 Financial Results
09/05/2018
CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other diseases, today reported business [...]
Accelerate Diagnostics reports Q1 2018 financial results
09/05/2018
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year [...]
Savara Reports First Quarter 2018 Financial Results and Provides Business Update
09/05/2018
Molgradex Phase 3 IMPALA study enrollment on track for completion in Q3 2018 AeroVanc Phase 3 AVAIL study enrollment on track for completion in Q1 2019 Molgradex Phase 2a OPTIMA study enrollment on track for completion [...]
FibroGen Reports First Quarter 2018 Financial Results
09/05/2018
Pamrevlumab Data to be Presented at ATS 2018 and ASCO 2018 Roxadustat U.S. Phase 3 Clinical Studies on Track to Readout in Fourth Quarter 2018 Conference Call Today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time SAN [...]
Collegium Reports First Quarter Financial Results and Provides Corporate Update
09/05/2018
Net revenue of $63.7 million, compared to $10.8 million in Q4 2017 Xtampza ER prescriptions grew by 72% in the first quarter Integration of the Nucynta franchise into the commercial organization Conference call [...]
Sientra Reports First Quarter 2018 Financial Results
09/05/2018
Achieves Highest Net Sales in Company’s History Received FDA Approval of PMA Supplement Launched OPUS™ Branded Breast Products and miraDry fresh™ Enhanced Protocol Completed Upsized Follow-on Public Offering of Common [...]

Pages